Alternatively, point mutations of the β-catenin coding gene CTNNB1 lead to alterations in the protein’s N-terminal Ser/Thr phosphorylation sites, thereby preventing phosphorylation by GSK3β and consequent degradation in some APC wild-type colorectal cancers (Morin et al., 1997). This evidence concerns the gene APC and colorectal cancer.